Neogenomics Inc
NASDAQ:NEO

Watchlist Manager
Neogenomics Inc Logo
Neogenomics Inc
NASDAQ:NEO
Watchlist
Price: 15.83 USD 0.06% Market Closed
Market Cap: 2B USD
Have any thoughts about
Neogenomics Inc?
Write Note

Neogenomics Inc
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Neogenomics Inc
Cost of Revenue Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Neogenomics Inc
NASDAQ:NEO
Cost of Revenue
-$360.3m
CAGR 3-Years
-8%
CAGR 5-Years
-15%
CAGR 10-Years
-25%
Thermo Fisher Scientific Inc
NYSE:TMO
Cost of Revenue
-$25B
CAGR 3-Years
-9%
CAGR 5-Years
-12%
CAGR 10-Years
-11%
Danaher Corp
NYSE:DHR
Cost of Revenue
-$8.6B
CAGR 3-Years
8%
CAGR 5-Years
-4%
CAGR 10-Years
0%
Mettler-Toledo International Inc
NYSE:MTD
Cost of Revenue
-$1.5B
CAGR 3-Years
-2%
CAGR 5-Years
-4%
CAGR 10-Years
-3%
Agilent Technologies Inc
NYSE:A
Cost of Revenue
-$2.9B
CAGR 3-Years
-1%
CAGR 5-Years
-5%
CAGR 10-Years
-11%
IQVIA Holdings Inc
NYSE:IQV
Cost of Revenue
-$9.9B
CAGR 3-Years
-3%
CAGR 5-Years
-7%
CAGR 10-Years
-10%

See Also

What is Neogenomics Inc's Cost of Revenue?
Cost of Revenue
-360.3m USD

Based on the financial report for Jun 30, 2024, Neogenomics Inc's Cost of Revenue amounts to -360.3m USD.

What is Neogenomics Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-25%

Over the last year, the Cost of Revenue growth was -9%. The average annual Cost of Revenue growth rates for Neogenomics Inc have been -8% over the past three years , -15% over the past five years , and -25% over the past ten years .

Back to Top